<DOC>
	<DOCNO>NCT03048110</DOCNO>
	<brief_summary>Evaluate effect probe CYP3A4 inhibitor inducer pharmacokinetics BAY1841788 ( ODM-201 )</brief_summary>
	<brief_title>Drug-drug Interaction ( DDI ) Study Assess ODM-201 Victim CYP3A4 Inhibition Induction</brief_title>
	<detailed_description />
	<mesh_term>Itraconazole</mesh_term>
	<mesh_term>Hydroxyitraconazole</mesh_term>
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy subject determine investigator medically qualify designee base medical evaluation include medical history , physical examination , laboratory test cardiac monitoring . Gender : Male . Age : 45 65 year ( inclusive ) screen visit . Race : White . Body mass index ( BMI ) : ≥18.0 ≤30 kg/m2 . Agree use condom effective contraception barrier method refrain sperm donation whole study ( start inform consent ) 3 month end treatment ODM201 . In addition , participant must agree utilize second reliable method contraception simultaneously . The second method use female partner childbearing potential one follow method : diaphragm cervical cap spermicide intrauterine device hormonebased contraception . Results alcohol test negative screen Study Day 1 . Medical surgical history Existing relevant diseases vital organ ( e.g . liver disease , heart disease ) , central nervous system ( example seizure ) organ ( e.g . diabetes mellitus ) . Incompletely cure preexisting disease assume absorption , distribution , metabolism , elimination effect study drug normal . Febrile illness within 1 week first study drug administration . A medical history risk factor Torsades de Pointes ( e.g . family history Long QT Syndrome ) arrhythmia . Known severe allergy , nonallergic drug reaction , ( multiple ) drug allergy ( exclude untreated , asymptomatic seasonal allergy like nonsevere hay fever time study conduct ) . Known history hypersensitivity ( know allergic reaction ) itraconazole , rifampicin ODM201 . Relevant hepatic disorder like cholestasis , disturbance bilirubin metabolism , progressive liver disease . Relevant renal disorder like recurrent glomerulonephritis , renal injury , renal insufficiency . However , history single episode uncomplicated nephrolithiasis prevent participation . Subjects porphyria . Subjects diagnose malignancy within past 5 year except cured skin basal carcinoma .</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>